Eun Joo Kang

2.9k total citations
83 papers, 1.4k citations indexed

About

Eun Joo Kang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Eun Joo Kang has authored 83 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 38 papers in Pulmonary and Respiratory Medicine and 20 papers in Surgery. Recurrent topics in Eun Joo Kang's work include Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Research Studies (14 papers) and Cancer Genomics and Diagnostics (9 papers). Eun Joo Kang is often cited by papers focused on Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Research Studies (14 papers) and Cancer Genomics and Diagnostics (9 papers). Eun Joo Kang collaborates with scholars based in South Korea, Japan and United States. Eun Joo Kang's co-authors include Yoon Ji Choi, Myung‐Ju Ahn, Yoon Hee Choi, Ho Jung An, Keon Uk Park, Sung Yong Lee, Jung Sun Kim, Jang Ho Cho, Se‐Hoon Lee and Keunchil Park and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Eun Joo Kang

77 papers receiving 1.4k citations

Peers

Countries citing papers authored by Eun Joo Kang

Since Specialization

Citations

This map shows the geographic impact of Eun Joo Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eun Joo Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eun Joo Kang more than expected).

Fields of papers citing papers by Eun Joo Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eun Joo Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eun Joo Kang. The network helps show where Eun Joo Kang may publish in the future.

Co-authorship network of co-authors of Eun Joo Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Eun Joo Kang. A scholar is included among the top collaborators of Eun Joo Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eun Joo Kang. Eun Joo Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17) 2024 ·ESMO Open ·Eun Joo Kang, Yaewon Yang, Sang-Ho Lee, Yu Jung Kim, Seungtaek Lim, (unknown), Yoon Ji Choi, Yong Jae Lee, Tae Min Kim, (unknown), Hee Kyung Ahn, (unknown), (unknown), So Yeon Oh, Woo Kyun Bae, Han Suk Ryu, Kang Hyun Park, KK Lee	2
2	Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01) 2023 ·Cancers ·Yun‐Gyoo Lee, Eun Joo Kang, Bhumsuk Keam, (unknown), Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Keun‐Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Hye Ryun Kim, Sung‐Bae Kim, Hyo Jung Kim, Hwan‐Jung Yun	0
3	Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma 2023 ·Head & Neck ·(unknown), Yoojoo Lim, Chan‐Young Ock, Gahee Park, Seonwook Park, (unknown), Minuk Ma, (unknown), Eun Joo Kang, Myung‐Ju Ahn, Keun‐Wook Lee, Jung Hye Kwon, Yaewon Yang, Yoon Hee Choi, Min Kyoung Kim, Jun Ho Ji, Tak Yun, (unknown), Bhumsuk Keam	5
4	A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas 2023 ·Cancer ·Jiyun Lee, Sehhoon Park, Hyun Ae Jung, Se‐Hoon Lee, Seyoung Seo, (unknown), JW Kim, (unknown), Eun Joo Kang, Ju Won Kim, Yoon Ji Choi, Byoung Yong Shim, (unknown), Lee Chun Park, Seong Hoon Shin, Jae‐Joon Kim, So Yeon Oh, Min Kyoung Kim, Myung‐Ju Ahn	9
5	613 A phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06) 2023 ·SHILAP Revista de lepidopterología ·Ju Won Kim, Hyo Jin Lee, (unknown), K. Jason, Sook Ryun Park, (unknown), In Gyu Hwang, Woo Kyun Bae, Jae Ho Byun, Jung Sun Kim, Eun Joo Kang, Jeeyun Lee, Sang Joon Shin, Kyong Hwa Park	1
6	Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma 2021 ·Clinical Cancer Research ·Eun Joo Kang, Myung‐Ju Ahn, Chan-Young Ock, Keun‐Wook Lee, Jung Hye Kwon, Yaewon Yang, Yoon Hee Choi, Min Kyoung Kim, Jun Ho Ji, Tak Yun, Byung‐Ho Nam, Sung‐Bae Kim, Bhumsuk Keam	39
7	Long‐term outcomes in patients with advanced and/or metastatic non–small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real‐world data (KCSG LU20‐11) 2021 ·Cancer ·Hong-Sik Kim, Dong‐Wan Kim, Miso Kim, Youngjoo Lee, Hee Kyung Ahn, Jang Ho Cho, Il Hwan Kim, Yun‐Gyoo Lee, Seong Hoon Shin, Song Ee Park, (unknown), Eun Joo Kang, Myung‐Ju Ahn	30
8	The Role of Chemotherapy in Patients With HER2-Negative Isolated Locoregional Recurrence of Breast Cancer: A Multicenter Retrospective Cohort Study 2021 ·Frontiers in Oncology ·Kyoungmin Lee, Sung Hoon Sim, Eun Joo Kang, Jae Hong Seo, Heejung Chae, Keun Seok Lee, Ji‐Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Seri Park, Yeon Hee Park, In Hae Park	4
9	Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG‐LU16‐07 2020 ·Thoracic Cancer ·Miso Kim, Bhumsuk Keam, Chan‐Young Ock, Se Hyun Kim, Yu Jung Kim, Sun Min Lim, Jin‐Soo Kim, Tae Min Kim, Sook Hee Hong, Mi Sun Ahn, Seong Hoon Shin, Eun Joo Kang, Dong‐Wan Kim, (unknown), Jong‐Il Kim, Jong Seok Lee, Joo‐Hang Kim, Dae Seog Heo	19
10	An Isoform of the Oncogenic Splice Variant AIMP2-DX2 Detected by a Novel Monoclonal Antibody 2020 ·Biomolecules ·Dae Gyu Kim, (unknown), Nam Hoon Kwon, (unknown), Semi Lim, Eun Joo Kang, Jihye Lee, Woo‐Young Seo, Arum Kim, Yoon Soo Chang, Hyunbo Shim, Sung‐Hoon Kim	0
11	Pulmonary function is implicated in the prognosis of metastatic non-small cell lung cancer but not in extended disease small cell lung cancer 2019 ·Journal of Thoracic Disease ·Suk‐young Lee, Yoon Ji Choi, Jae Hong Seo, Sung Yong Lee, Jung Sun Kim, Eun Joo Kang	10
12	Attitudes of the General Public, Cancer Patients, Family Caregivers, and Physicians Toward Advance Care Planning: A Nationwide Survey Before the Enforcement of the Life-Sustaining Treatment Decision-Making Act 2018 ·Journal of Pain and Symptom Management ·Hye Yoon Park, Young Ae Kim, Jin-Ah Sim, Jihye Lee, Hyewon Ryu, Jung Lim Lee, Chi Hoon Maeng, Jung Hye Kwon, Yu Jung Kim, Eun Mi Nam, (unknown), Eun‐Kee Song, Kyung Hae Jung, Eun Joo Kang, Jung Hun Kang, Young Ho Yun	26
13	Comparison of attitudes towards five end-of-life care interventions (active pain control, withdrawal of futile life-sustaining treatment, passive euthanasia, active euthanasia and physician-assisted suicide): a multicentred cross-sectional survey of Korean patients with cancer, their family caregivers, physicians and the general Korean population 2018 ·BMJ Open ·Young Ho Yun, Kyoung‐Nam Kim, Jin-Ah Sim, Shin Hye Yoo, Miso Kim, Young Ae Kim, (unknown), (unknown), Eun‐Kee Song, Jung Hun Kang, Jung Hye Kwon, Jung Lim Lee, Eun Mi Nam, Chi Hoon Maeng, Eun Joo Kang, Young Rok, Yoon Seok Choi, Kyung Hae Jung	24
14	OA10.05 An Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients with Uncommon EGFR Mutation(KCSG-LU15-09) 2018 ·Journal of Thoracic Oncology ·(unknown), Jong‐Mu Sun, (unknown), Jin Seok Ahn, K. Park, (unknown), Eun Joo Kang, Yoon Hee Choi, Kyae Hyung Kim, Ho Jung An, Hyun Woo Lee, Myung‐Ju Ahn	12
15	Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: a retrospective study 2018 ·BMC Cancer ·Jung Sun Kim, Eun Joo Kang, Dae Sik Kim, Yoon Ji Choi, (unknown), Hong Jun Kim, (unknown), Jun Suk Kim	21
16	A Case Report of Primary Pericardial Malignant Mesothelioma Treated with Pemetrexed and Cisplatin 2017 ·Journal of Korean Medical Science ·Jung Sun Kim, Sang Yup Lim, (unknown), Eun Joo Kang, Yoon Ji Choi	4
17	Positive response of a primary malignant pericardial mesothelioma to pemetrexed plus cisplatin followed by pemetrexed maintenance chemotherapy: A case report 2016 ·Oncology Letters ·(unknown), (unknown), Min-Jeong Kim, (unknown), Hong Jun Kim, Suk‐young Lee, Eun Joo Kang	5
18	Regression of Hyperplastic Gastric Polyp after Helicobacter pylori Eradication 2011 ·Clinical Endoscopy ·(unknown), Jae Won Yun, (unknown), Wonjae Choi, Seung Han Kim, Jung Wan Choe, Mi‐Na Kim, Eun Joo Kang, (unknown), Moon Kyung Joo, Beom Jae Lee, Young‐Tae Bak, Sang Woo Lee, (unknown)	5
19	Clinical Comparison of Maternal Characteristics and Pregnancy Outcomes between Gestational Diabetes and General Obstetric Population. 2001 ·Korean Journal of Obstetrics & Gynecology ·(unknown), Mee‐Ran Kim, Mi Young􀀁 Choi, Eun Joo Kang, (unknown), (unknown)	4
20	Conservative Treatment of Cervical Pregnancy with MTX Followed by Therapeutic Curettage. 2001 ·Korean Journal of Obstetrics & Gynecology ·Eun Joo Kang, (unknown), (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact